Intervacc's IPO

Intervacc raised a round of funding on April 07, 2017. Investors include Public.

Intervacc (NASDAQ Stockholm: IVACC) is a Swedish company active in the biotechnology sector. The company's veterinary vaccines, such as Strangvac, are based on recombinant proteins, to meet the increa…

Articles about Intervacc's IPO: